Clinical Trial

Reliability and Performance Analysis of the Use of Tissue Flossing for Blood Flow Restriction.

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated May 31, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Blood flow restriction (RFS) is a widely studied technique that combines low-intensity exercise with vascular occlusion, resulting in muscular benefits. However, its application is challenging due to methodological variations and equipment costs. Tissue Flossing (TF) appears as an affordable alternative, but lacks solid scientific evidence.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-10-04; most recent amendment 2025-05-27.
Status change: Not Yet Recruiting → Enrolling by Invitation 2024-11-08
Trial Details
NCT Number NCT06075901
Lead Sponsor Paulista University
Conditions Hypertrophy, Muscle Strength
Enrollment 136 participants
Start Date 2024-08-01
Primary Completion 2025-12 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2025-05-31